That's cow guts.................... NEW LINK was talked about by Robinson in his testimony. I have went by their head quarters. They among others Robinson said he wanted many different cures ZMAPP in animal and Plant. My question to you is will they become customers as it changes to plant antibodies one day? Do you think it will stay viable using cow gut? Who has the platform to help it change? Now that IBIO has 3rd generation technologies will other vaccine companies want slower manufacturing methods or eventually change. YOU do understand the different technologies and generations right? The first being I feel they will be used. My question to you is do you understand this company at all? Its not about cow guts and animal antibodies, proteins. Its about revolutionary game changing technologies. Transgenic plants are plants that have been genetically engineered, a breeding approach that uses recombinant DNA techniques to create plants with new characteristics. They are identified as a class of genetically modified organism (GMO). Stable cell lines offer consistent product quality, but clone (grow) the same plant over and over.
With transient, the induction of major biological or therapeutic effects on the basis of "hit-and-run" mechanisms. With transient they deliver into the plant, the outside intruders , the plant identifies the intruders and make the desired variety of proteins – including antibodies, biochemical targets of interest, vaccines, viral vectors and virus-like particles – can be rapidly expressed. 1st generation, transgenic –plants are genetically engineered – slow process… . 2nd Generation- is based on transient virus-delivery of genes into non-transgenic plants,( non-engineered plant) . You target the whole plant and fundamentally alter a host cell’s DNA changing the plant …… 3rd Generation- there is no need to isolate and expand rare, high-producing cell clones to production level. A gene of interest can be cloned and inserted into the iBioLaunch vectors and be ready for production at scale within a month’s time. Using the plant to extract antibodies many times, (optimizing). In addition, the transient nature of the expression system allows the accumulation of massive amounts of desired protein over a four- to seven-day period, after which time purification can begin.
I tell you what, it came close enough to the 80 cents before Ebola. I am Mad, but not towards the company. Again you are right and many will fall victim to price manipulation if you sell. Its a cruel street out there when you have to battle shorts , bashers and competition on line. they can not battle with the science or technology. I was very week a week ago and panicked a little. I think it was VVVRRRoom that pointed it out. The manipulation and competition are tough. ADAM refused to acknowledge the platform or Market potential. Melissa ignores the real 10K facts and what is actually published. The lawyers are in LA, LA land and time is running out for the shorts, manipulation and their games. If I was forced to guess what happen today, I would guess was some body wanting to add more cheaper shares so he dumped a bunch as Aspire didn't buy. I bet he added a whole lot more after the dump.
I am sure he understand the patents, basic science, and has talked to Robert personally as his understand on different points were to in depth not to have been coached. He may be a fast study as I have spent countless hour my self and cant touch what he has printed or his understanding. He has a grasp for whats going on some times post facts contrary to what longs want to hear. Its not all sugar and roses here and he has brought that out on occasions. I am a pumper and he is a lot more fair towards this company. Companies have the best science and best odds all the time to lose do to financing or better technologies. I will go down swinging stating the risk reward favor longs.
I am here if you really have a question about the suits from PLANTFORM or the taking advantage of Ebola with the offering done quarters ago and on the 10K. Read the Robinson testimony pages 7 and 8 about the presidents money. Go to Alpha and read the BiotechMD SUMMARY......... You will read about major pharma players in the news getting EROPE , WHO contracts and other Ebola initiatives. Some may even have the $%^&* to say Barda has given the orders to other players.... This may be true also but read the testimony about many players being added. READ about PLANT and ANIMAL ZMAPP. These shorts and bashers will scare you as they are pros. just refresh what Robert has stated about the Patents and 3rd generation sciences he has witnessed and successfully used live fire..... GE GATES ,BRAZIL, JAPAN ,CHINA and Aspire have read it. If Melissa grows some #$%^&*() I will explain it to her on Alpha or here.
I have not seen one legitimate reason for the law suit yet. Robert and the 10K speaks louder then the lawyers. They have nothing. Melissa is and had nothing and ADAM was very much out of character....Robert got 1.3 out of the last offering ... ........ Why would he get less now if he even chooses to make it public or private? He wants access to cash if ZMAP, ICON, GSK and AMGEN come calling...... Wouldn't you !It is nice to have it in case another company tries to buy us.
ONLY a dim witted twit named Melissa would think they are real. Check the facts about the offering going way back. ONLY a bonehead named ADAM would not have the facts that the average share bout was 1.3..... The bonehead only looked at EBOLA instead of the under valued stock that did not belong at 80 cents before EBOLA. In no way did he do over 15 minutes off DD as the guy looks on the up and up. He is not that stupid. The lawyers have nothing but a hit piece from a self proclaimed short. Congrats at their prize as they did very well on their shots. I would not have prostituted my self for it.
Makes you think ASPIRES knows what they are doing buying the shares at .44 to 1.6 and averaging 1.3. How many cheap shares do you think theStreet will be adding? my guess is its time for them to cover and go long.
that would mean he invest like Vanguard Group, Inc. (The)
BlackRock Fund Advisors
State Street Corporation and BlackRock Institutional
Northern Trust Corporation and
Plug could fly with more major contracts........... Im more of a Ballard person that thinks making the cells and having the IT might be more rewarding in time. There are a lot of warehouses and manufactures out there..... Think AMAZON robot meeting the battery industry? I am looking at plug as it falls. Small batteries could be another area. They have just been used and abused by financing and development. Acceptance there again has been slow. The 20% short position could fry their also.
He prays to god for more ZMAPP as nurses and doctors leave their post and you find that? Ask him what drug he would use on doctors? Your Sapphire researcher seams to think they can modify ZMAPP to a couple doses. All those post and its still the number one BARDA drug? Is any body listening?
I remember that stock was testing DNA solutions. They have a couple drugs in phase one...... IBIO has a platform tested, used and approved. I am sure there are many Robert left out as the field is huge and hundreds of players. DIDN"T VICAL use in there studies a four legged Schinzo right before it ate the cheese. I am real sure you feel threatened by them as they will make a difference. To put things in perspective the sky has a greater chance of falling. That would be on page 13527374658900 of the disclaimer if every thing under the sun was on the 10K. .
The article was a slam DUNK.. .. Its a matter of time.... *** In every bubble , outside of a rare few companies having a true groundbreaking catalyst during the cycle, they inevitably fall dramatically and others have the technology and ability to make a difference- CHANGING THE GAME = The ZMAPP use will flip the switch and will generate renewed interest in this space. IBIO is extremely well-positioned given results to date demonstrating bio-equivalency across a comprehensive and diverse range of biologics and difficult to produce recombinant proteins in a multi-billion dollar space. We could see a paradigm shift in the PPS. There is a good chance of news on many IBIO fronts. Additional IBIO commercialization’s and future success based on the superiority of the technology and 3rd generation sciences. We will see advancements as it is very feasible with its pipeline though the approval pathways. The first BARDA news with tobacco plants being mass produced creates a very real market for PMP's. The Ibiolaunch platform is relevant to all currently marketed therapeutic proteins as well as new drug discovery. The company is substantially undervalued. ONE day many of these guys will look back and say - so that's what they were talken about-
WHY IBIOLaunch- IT IS versatile , PROVEN and TESTED. The Ibiolaunch platform in terms of cost, speed, scalability, and surge capacity, this platform is valuable to the government in its ability to counter an epidemic or pandemic as well as a bio-terrorism threat. Look at the beginnings with GCON, TEXAS A&M Caliber and Kentucky. A Governments function is the protection of its citizens, and leveraging the Ibiolaunch platform can result in both increased preparation and responsiveness in this regard. THUS we have BARDA, DOD and the Health Departments Task orders. Using the fully contained and completely automated process, a target could be produced on an aircraft carrier or at the site of an epidemic/pandemic outbreak or bio-terrorism attack. With GE and the IBIO platform countries can move PODS and small facilities to where they are needed.
Additionally, the Ibiolaunch technology enables a bio-equivalent vaccination to be produced using less antigen, and in a singular regimen. The company has performed the related preclinical work using Department of Defense funding to provide a vaccine candidate for an anthrax/plague combination vaccine that requires only one dose. NOW there is a Presidents emergency fund designed for Tobacco and plant serums and ZMAPP is a lead contender. . We are setting on the edge of a movement in PMP following the EBOLA outbreak.
Third Party Investments in Ibiolaunch: Vaccine Applications
The Bill & Melinda Gates Foundation and the Sabin Vaccine Institute
• $33.3 million for Ibiolaunch platform applications
• Avian Influenza Vaccine - $ 11.4 million
• Malaria Vaccine - $ 13.3 million
• Sleeping Sickness Vaccine - $ 8.2 million
• Hookworm Vaccine - $ 0.4 million
United States Government-grants from the Department of Defense are highly likely to continue • $37.4 million for Ibiolaunch platform applications
• Accelerated Manufacturing Program - $ 14.8 million
• Influenza Vaccine - $ 4.4 million
• Plague-Anthrax Combination Vaccine - $ 18.2 million
• Development of Chemical Reagents - $1.5 million
With 3rd generation sciences Licensing could take off = If they can strike deals with MAPP and ICON. The Icon Genetics unit of Bayer AG is currently conducting a Phase 1 clinical trial of individualized cancer therapy based on their transient expression technology for producing proteins in plants. PIPELINE FOR MAPP Clostridium, HIV/HSV, Junin, Marburg, a repertory Virus, Risin, Staphylococcal enterotoxin, encephalitis. Experts like James Crowe say Ebola is out of control.... Ebola has went through 300 genetic changes so far... Erica Sapphires tricks to treat Ebola is worth a quick read. . She fears Ebola could mutate with forms of Marburg and Hemorrhagic fever. Funds from the Presidents Emergency request looks like the hope for Zmapp and tobacco based drugs is alive. This was from the Robinson testimony. The rational for teamwork among the different people that have a piece of the puzzle was dually noted by your article. Thank you for getting with Robert and I thank Robert for his time to set the record straight on rumors and innuendos. I believe with co-operation and all hands on deck we stand a better chance.
* Players involved in the creation of Caliber Biotherapeutics and likely the Texas A&M proposal have long standing relationships with Robert Erwin.
* Robert Erwin's connections with multiple players in the PMP front and companies likely active in the Government response to Ebola is not only good for iBio but also MAPP Biopharmaceuticals.
* iBio has many torches to light the way going forward so is far greater than anything related to Ebola.
* Even if iBio fails to become part of the Ebola response the ZMAPP production ramp is a huge catalyst for PMPs. Success with ZMAPP would be a pivotal event for the PMP movement.
* The existence of ZMAPP and the request to ramp its production is evidence to institutional investors and big pharma of the potential to produce game changing biotherapeutics/vaccines through plant methodology. ** The savings to government expenditure alone would be measured in the billions. ZMAPP has already been acknowledged as one of the most promising treatments available for Ebola. The president has provided extra funding for tabacco and animal antibody solutions. This was in the BARDA Directors (Robinson) testimony on page 7&8 we have heard about on the boards. *****Barriers broke- To date there have been no FDA approved plant-made pharmaceuticals (PMPs). This has made a barrier to entry for iBio and any other companies focused on PMP production. ZMAPP is a game changer…The drug Doctors give each other-tested in the field … ** IBIO with other companies will benefit from Ebola and many diseases. Its not all or none ** IBIO is a technology platform research company w/without ebola- iBio would return to business as usual prior to Ebola crisis ** If any one of their many catalysts come to fruition their valuation can easily meet at least 250 million market cap in the short term. **) Many successes, rapid fire test , DARPA, Caliber, Novicci, GE, GATES history, partners, patents and defense contracts. ** huge markets measured in billions *** In every bubble , outside of a rare few companies having a true groundbreaking catalyst during the cycle, they inevitably fall dramatically and others have the technology and ability to make a difference- CHANGE THE GAME or MAKE A paradigm switch Do your own DD and see for yourself.